Certified. Responsive. Compassionate.
Leading the Science
Partnering with top biotech and biopharma to bring breakthrough treatments to patients.
Patient-Centered Care
Studies designed around your needs and real experiences.
Inclusive by Design
Multilingual staff and diverse participation at every level.
Compensated Participation
Fair payment for your time and contribution.
Available Studies
IBD Clinical Trial
The purpose of this research while administering Vedolizumab (Entyvio) is to test the short and long-term decrease or disappearance of symptoms associated with moderate to severely active Crohn’s Disease (CD) or Ulcerative Colitis (UC), understand the ease of switching Vedolizumab from intravenous to Vedolizumab subcutaneous, collect information on the reduction of impact on the physical and mental health.
Benefits
-
Study-related care from a gastroenterologist at no cost
-
Compensation for your time and participation
-
Reimbursement for study-related travel
-
Study medication provided at no cost
Location
Queens, New York
Duration
72 Weeks